Kimberly-Clark markets anti-viral facial tissue to office buildings, schools

January 31, 200—Buoyed by consumer response to its new KLEENEX Anti-Viral Facial Tissue, Kimberly-Clark Professional is making the product available to the away from home market.

KLEENEX Anti-Viral Facial Tissue is strong enough to stand up to a cold or flu virus, yet gentle enough for everyday use. It relies on a patented, super-premium three-ply tissue design with a moisture-activated middle layer that is treated with an anti-viral formula. When moisture from a cough or sneeze hits the middle layer, KLEENEX Anti-Viral Facial Tissue begins working immediately, ultimately killing 99.9 percent of cold and flu viruses in the tissue within 15 minutes. The formula is made from citric acid and sodium lauryl sulfate, common ingredients found in everyday consumer products.

In addition to the moisture-activated middle layer, which kills 99.9 percent of cold and flu viruses in the tissue, a subtle blue dot pattern on the middle layer visually distinguishes KLEENEX Anti-Viral Facial Tissue from other facial tissue products. KLEENEX Anti-Viral Facial Tissue is available in upright, 60-count Boutique packages.

For more information, visit the Kimberly-Clark Professional Web site.